鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/26 | 3,675 | 3,705 | 3,650 | 3,660 | -15 | -0.4% | 19,200 |
| 2024/07/25 | 3,665 | 3,720 | 3,665 | 3,675 | -20 | -0.5% | 23,400 |
| 2024/07/24 | 3,730 | 3,730 | 3,680 | 3,695 | -25 | -0.7% | 15,800 |
| 2024/07/23 | 3,700 | 3,735 | 3,675 | 3,720 | +45 | +1.2% | 11,900 |
| 2024/07/22 | 3,715 | 3,720 | 3,665 | 3,675 | -55 | -1.5% | 15,000 |
| 2024/07/19 | 3,700 | 3,740 | 3,690 | 3,730 | -20 | -0.5% | 22,200 |
| 2024/07/18 | 3,720 | 3,795 | 3,705 | 3,750 | ±0 | ±0% | 19,500 |
| 2024/07/17 | 3,775 | 3,775 | 3,730 | 3,750 | -5 | -0.1% | 18,200 |
| 2024/07/16 | 3,790 | 3,820 | 3,730 | 3,755 | -60 | -1.6% | 22,500 |
| 2024/07/12 | 3,705 | 3,835 | 3,705 | 3,815 | +85 | +2.3% | 38,900 |
| 2024/07/11 | 3,735 | 3,755 | 3,695 | 3,730 | -5 | -0.1% | 50,800 |
| 2024/07/10 | 3,725 | 3,770 | 3,705 | 3,735 | +10 | +0.3% | 29,300 |
| 2024/07/09 | 3,760 | 3,805 | 3,725 | 3,725 | -35 | -0.9% | 27,600 |
| 2024/07/08 | 3,735 | 3,765 | 3,685 | 3,760 | +25 | +0.7% | 48,400 |
| 2024/07/05 | 3,750 | 3,750 | 3,710 | 3,735 | -15 | -0.4% | 11,500 |
| 2024/07/04 | 3,700 | 3,750 | 3,690 | 3,750 | +40 | +1.1% | 18,900 |
| 2024/07/03 | 3,665 | 3,740 | 3,665 | 3,710 | +40 | +1.1% | 37,700 |
| 2024/07/02 | 3,680 | 3,705 | 3,665 | 3,670 | -20 | -0.5% | 16,400 |
| 2024/07/01 | 3,675 | 3,705 | 3,660 | 3,690 | +15 | +0.4% | 15,500 |
| 2024/06/28 | 3,700 | 3,705 | 3,660 | 3,675 | -25 | -0.7% | 19,100 |
| 2024/06/27 | 3,700 | 3,700 | 3,660 | 3,700 | -50 | -1.3% | 41,600 |
| 2024/06/26 | 3,745 | 3,770 | 3,720 | 3,750 | +30 | +0.8% | 75,800 |
| 2024/06/25 | 3,710 | 3,775 | 3,700 | 3,720 | +20 | +0.5% | 30,400 |
| 2024/06/24 | 3,730 | 3,740 | 3,685 | 3,700 | -15 | -0.4% | 20,900 |
| 2024/06/21 | 3,660 | 3,725 | 3,635 | 3,715 | +55 | +1.5% | 71,100 |
| 2024/06/20 | 3,635 | 3,705 | 3,635 | 3,660 | ±0 | ±0% | 47,900 |
| 2024/06/19 | 3,580 | 3,660 | 3,575 | 3,660 | +115 | +3.2% | 35,900 |
| 2024/06/18 | 3,580 | 3,590 | 3,545 | 3,545 | -35 | -1% | 9,800 |
| 2024/06/17 | 3,580 | 3,615 | 3,530 | 3,580 | -40 | -1.1% | 25,900 |
| 2024/06/14 | 3,600 | 3,665 | 3,580 | 3,620 | +5 | +0.1% | 50,800 |
| 2024/06/13 | 3,645 | 3,685 | 3,610 | 3,615 | -35 | -1% | 26,000 |
| 2024/06/12 | 3,680 | 3,700 | 3,645 | 3,650 | -30 | -0.8% | 13,200 |
| 2024/06/11 | 3,730 | 3,730 | 3,675 | 3,680 | -50 | -1.3% | 22,800 |
| 2024/06/10 | 3,720 | 3,750 | 3,700 | 3,730 | +30 | +0.8% | 18,100 |
| 2024/06/07 | 3,685 | 3,705 | 3,665 | 3,700 | +5 | +0.1% | 13,300 |
| 2024/06/06 | 3,750 | 3,750 | 3,695 | 3,695 | -70 | -1.9% | 11,200 |
| 2024/06/05 | 3,800 | 3,830 | 3,745 | 3,765 | -35 | -0.9% | 17,400 |
| 2024/06/04 | 3,820 | 3,830 | 3,760 | 3,800 | -5 | -0.1% | 16,600 |
| 2024/06/03 | 3,805 | 3,855 | 3,785 | 3,805 | +20 | +0.5% | 14,500 |
| 2024/05/31 | 3,730 | 3,805 | 3,730 | 3,785 | +75 | +2% | 35,300 |
| 2024/05/30 | 3,650 | 3,755 | 3,640 | 3,710 | +45 | +1.2% | 28,500 |
| 2024/05/29 | 3,700 | 3,720 | 3,645 | 3,665 | -30 | -0.8% | 18,800 |
| 2024/05/28 | 3,745 | 3,755 | 3,695 | 3,695 | -50 | -1.3% | 16,900 |
| 2024/05/27 | 3,730 | 3,745 | 3,710 | 3,745 | +5 | +0.1% | 18,900 |
| 2024/05/24 | 3,780 | 3,780 | 3,725 | 3,740 | -45 | -1.2% | 15,600 |
| 2024/05/23 | 3,730 | 3,800 | 3,725 | 3,785 | +45 | +1.2% | 17,300 |
| 2024/05/22 | 3,800 | 3,800 | 3,740 | 3,740 | -45 | -1.2% | 16,900 |
| 2024/05/21 | 3,850 | 3,870 | 3,770 | 3,785 | -65 | -1.7% | 31,500 |
| 2024/05/20 | 3,880 | 3,905 | 3,840 | 3,850 | -45 | -1.2% | 30,500 |
| 2024/05/17 | 3,890 | 3,905 | 3,865 | 3,895 | +5 | +0.1% | 20,500 |
1～
50
件表示中 / 3506件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 366,000円 | +7.3% | +16.8% | 3.28% | 21.89倍 | 0.86倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| ジーエヌアイ | 228,000円 | +52.1% | +23.3% | 0.00% | 16.17倍 | 3.38倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 杏林製薬 | 170,100円 | +3.2% | +4.5% | 3.06% | 19.54倍 | 0.75倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 238,400円 | +7.6% | +57.5% | 2.22% | 18.43倍 | 1.81倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ＪＣＲファーマ | 61,700円 | -3.7% | -36.7% | 3.24% | 20.81倍 | 1.39倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
